Narrow search
Showing 1 - 10 of 6,959
Cover Image
Accelerating vaccine innovation for emerging infectious diseases via parallel discovery
Barberio, Joseph; Becraft, Jacob; Ben Chaouch, Zied; … - In: Entrepreneurship and innovation policy and the economy … 2 (2023), pp. 9-39
Persistent link: https://www.econbiz.de/10015049952
Cover Image
How does basic research improve innovation performance in the world's major pharmaceutical firms?
Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424
Persistent link: https://www.econbiz.de/10013170079
Cover Image
Big Pharma, little science? : a bibliometric perspective on Big Pharma's R&D decline
Rafols, Ismael; Hopkins, Michael M.; Hoekman, Jarno; … - In: Technological forecasting & social change : an … 81 (2014), pp. 22-38
Persistent link: https://www.econbiz.de/10010403289
Cover Image
Pharmaceutical innovation : revolutionizing human health
Landau, Ralph (ed.); Achilladelis, Basil (contributor);  … - 1999
Persistent link: https://www.econbiz.de/10001423161
Cover Image
COVID-19 vaccines and the role of patents
Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491
Persistent link: https://www.econbiz.de/10012800211
Cover Image
A cross-country index of intellectual property rights in pharmaceutical inventions
Liu, Ming; La Croix, Sumner J. - In: Research policy : policy, management and economic … 44 (2015) 1, pp. 206-216
Persistent link: https://www.econbiz.de/10011317950
Cover Image
Prices and related controversies in the biopharmaceutical industry
Manning, Richard L. - In: International journal of the economics of business 25 (2018) 1, pp. 157-166
Persistent link: https://www.econbiz.de/10011881466
Cover Image
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Correa, Carlos María - 2020
Persistent link: https://www.econbiz.de/10012433977
Cover Image
Compulsory licensing as a remedy against excessive pricing of life-saving medicines
Kianzad, Behrang - 2024
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
Cover Image
Cheap Drugs at What Price to Innovation : Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation?
Chien, Colleen V. - 2014
The patent system is built on the premise that patents provide an incentive for innovation by offering a limited … monopoly to patentees. The inverse assumption that removing patent protection will hurt innovation has largely prevented the … no uniform decline in innovation by companies affected by compulsory licenses and find very little evidence of a negative …
Persistent link: https://www.econbiz.de/10014029626